MALAT1 and melanoma: These findings establish a new MALAT1–miR-211–SIRT1 signaling pathway that may provide long-term protection to the keratinocytes of the amelanotic skin of vitiligo patients, potentially explaining their lower risk of developing melanoma and non-melanoma skin cancer [120].